{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:08:26Z","timestamp":1771607306316,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.forsciint.2019.109958","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T12:32:17Z","timestamp":1568291537000},"page":"109958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The prevalence of gamma-hydroxybutyrate (GHB) in motor vehicle drivers and its co-administration with amphetamine type substances (ATS) in Queensland, Australia (2011\u20132018)"],"prefix":"10.1016","volume":"303","author":[{"given":"Andrew","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenore","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.forsciint.2019.109958_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"GABA, gamma-hydroxybutyric acid, and neurological disease","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.forsciint.2019.109958_bib0010","first-page":"4654","article-title":"Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome","volume":"19","author":"Busard\u00f2","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.forsciint.2019.109958_bib0015","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/ijerph6061917","article-title":"Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review","volume":"6","author":"Caputo","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.forsciint.2019.109958_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","article-title":"GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome","volume":"13","author":"Busard\u00f2","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.forsciint.2019.109958_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02791072.2007.10399870","article-title":"Experiences of gamma hydroxybutyrate ingestion: a focus group study","volume":"39","author":"Barker","year":"2007","journal-title":"J. Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.forsciint.2019.109958_bib0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jat\/31.9.566","article-title":"Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases","volume":"31","author":"Jones","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.109958_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12024-008-9040-1","article-title":"Driving under the influence of gammahydroxybutyrate (GHB)","volume":"4","author":"Jones","year":"2008","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.forsciint.2019.109958_bib0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jat\/28.6.512","article-title":"Addicted to driving under the influence\u2014a GHB\/GBL case report","volume":"28","author":"Couper","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.109958_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0379-0738(03)00044-6","article-title":"Forensic cases involving the use of GHB in the Netherlands","volume":"133","author":"Bosman","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109958_bib0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1520\/JFS15070J","article-title":"GHB and driving impairment","volume":"46","author":"Couper","year":"2001","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2019.109958_bib0055","series-title":"Queensland Government, Transport Operations (Road Use Management) Act","year":"1995"},{"key":"10.1016\/j.forsciint.2019.109958_bib0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10508-009-9495-5","article-title":"Methamphetamine and viagra use: relationship to sexual risk behaviors","volume":"40","author":"Fisher","year":"2011","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.forsciint.2019.109958_bib0065","series-title":"European Monitoring Centre for Drugs and Drug Addiction","author":"Perspectives on Drugs: injection of synthetic cathinones","year":"2015"},{"key":"10.1016\/j.forsciint.2019.109958_bib0070","first-page":"e8","article-title":"New \u201cLethal highs\u201d: a case of a deadly cocktail of GHB and mephedrone","volume":"273","author":"Aromatario","year":"2012","journal-title":"For. Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109958_bib0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jat\/bkw058","article-title":"Fatal combination with 3-methylmethcathinone (3-MMC) and gamma-hydroxybutyric acid (GHB)","volume":"40","author":"Jamey","year":"2016","journal-title":"J. Anal. Tox."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109958_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00450618.2015.1034778","article-title":"MDPV in Queensland drivers","volume":"48","author":"Griffiths","year":"2016","journal-title":"Aust. J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2019.109958_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aap.2013.12.007","article-title":"Results of the Queensland 2007-2012 roadside drug testing program: the prevalence of three illicit drugs","volume":"65","author":"Davey","year":"2014","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2019.109958_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.forsciint.2017.07.028","article-title":"Smoke on the water\u2013oral fluid analysis at sea","volume":"278","author":"Griffiths","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109958_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2007.02.009","article-title":"Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers","volume":"173","author":"Dresen","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109958_bib0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.forsciint.2012.04.009","article-title":"Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy","volume":"221","author":"Lott","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"10","key":"10.1016\/j.forsciint.2019.109958_bib0105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00228-010-0870-x","article-title":"Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway","volume":"66","author":"Al-Samarraie","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2019.109958_bib0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1872208309666150504143155","article-title":"GHB in biological specimens: which cutoff levels should be taken into consideration in forensic toxicological investigation","volume":"8","author":"Busard\u00f2","year":"2014","journal-title":"Rec. Pat. Biotechnol."},{"key":"10.1016\/j.forsciint.2019.109958_bib0115","series-title":"Australian Bureau of Statistics \u2013 3218.0 Population Estimates by Local Government Area (ASGS 2018), 2017 to 2018. Estimated Resident Population, Local Government Areas, Queensland","year":"2019"},{"key":"10.1016\/j.forsciint.2019.109958_bib0120","series-title":"Proceedings of the 54th Conference of the International Association of Forensic Toxicologists","article-title":"A series of cases involving AB-CHMINACA in the blood of drivers suspected of impaired driving in Queensland, Australia","author":"Griffiths","year":"2016"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:56:22Z","timestamp":1759946182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073819303706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"alternative-id":["S0379073819303706"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109958","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of gamma-hydroxybutyrate (GHB) in motor vehicle drivers and its co-administration with amphetamine type substances (ATS) in Queensland, Australia (2011\u20132018)","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109958"}}